AGP Picks
View all

Sci-Tech News Network
Provided by AGP

Sci-Tech News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Network.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 4, 2026

全球最佳旅行“平替”，避开拥挤人潮
Aug. 4, 2026

全球最佳旅行“平替”，避开拥挤人潮

Indeterminate GlobeNewswire
全球最佳旅遊「平替」目的地，遠離過度旅遊的喧囂
Aug. 4, 2026

全球最佳旅遊「平替」目的地，遠離過度旅遊的喧囂

Indeterminate GlobeNewswire
Michael van Keulen joins Omnea as CPO in Residence
Aug. 4, 2026

Michael van Keulen joins Omnea as CPO in Residence

Indeterminate GlobeNewswire
Orbs Launches Community Governance Vote to Establish Its DAO Framework
Aug. 4, 2026

Orbs Launches Community Governance Vote to Establish Its DAO Framework

Indeterminate GlobeNewswire
AMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture Collection
Aug. 4, 2026

AMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture Collection

Indeterminate GlobeNewswire
Logitech G to Ignite Gaming Culture in Warsaw with its flagship event, Logitech G PLAY 2026
Aug. 4, 2026

Logitech G to Ignite Gaming Culture in Warsaw with its flagship event, Logitech G PLAY 2026

Indeterminate GlobeNewswire
Global Power Solutions Joins Infrastructure Masons (iMasons), Strengthening Focus on Decentralized Power for AI and Data Center Infrastructure
Aug. 4, 2026

Global Power Solutions Joins Infrastructure Masons (iMasons), Strengthening Focus on Decentralized Power for AI and Data Center Infrastructure

Indeterminate GlobeNewswire
NXP Trimension Ultra-Wideband Powers BMW Group’s Digital Key Plus and Presence Detection
Aug. 4, 2026

NXP Trimension Ultra-Wideband Powers BMW Group’s Digital Key Plus and Presence Detection

Indeterminate GlobeNewswire
Financial Firms Face More AI-Assisted Fraud Activity – and Appear Better Prepared, Regula Study Finds
Aug. 4, 2026

Financial Firms Face More AI-Assisted Fraud Activity – and Appear Better Prepared, Regula Study Finds

Indeterminate GlobeNewswire
The5ers Launches Trader Rewards Through the TradePoints Ecosystem
Aug. 4, 2026

The5ers Launches Trader Rewards Through the TradePoints Ecosystem

Indeterminate GlobeNewswire
IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by Over EUR 102 million Order Backlog
Aug. 4, 2026

IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by Over EUR 102 million Order Backlog

Indeterminate GlobeNewswire
LeverageOne Strengthens Its Integrated Technology Platform for the Brokerage Industry
Aug. 4, 2026

LeverageOne Strengthens Its Integrated Technology Platform for the Brokerage Industry

Indeterminate GlobeNewswire
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
Aug. 4, 2026

Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease

Indeterminate GlobeNewswire
Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques
Aug. 4, 2026

Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques

Indeterminate GlobeNewswire
Wix Reports Second Quarter 2026 Results
Aug. 4, 2026

Wix Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire
Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Aug. 4, 2026

Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Indeterminate GlobeNewswire
Rapid Nutrition Joins Global Conversation on the Future of AI-Driven HealthTech
Aug. 4, 2026

Rapid Nutrition Joins Global Conversation on the Future of AI-Driven HealthTech

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.